Cleared Traditional

K223440 - Plasma Pen (Plasma MD); Plasma Pen (Plasma +)
(FDA 510(k) Clearance)

Mar 2023
Decision
108d
Days
Class 2
Risk

K223440 is an FDA 510(k) clearance for the Plasma Pen (Plasma MD); Plasma Pen (Plasma +). This device is classified as a Low Power Electrosurgical Devices For Skin Lesion Destruction (Class II - Special Controls, product code QVJ).

Submitted by Plasma Concepts (Woburn, US). The FDA issued a Cleared decision on March 2, 2023, 108 days after receiving the submission on November 14, 2022.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4400. For The Removal And Destruction Of Skin Lesions In General Dermatological Procedures, Also Referred To As Plasma Pen Devices, Which Generates Electrical Arc In The Ambient Air Between An Electrical Probe Tip And The Skin And Cause Intended Tissue Damage For The Removal And Destruction Of Skin Lesions.

Submission Details

510(k) Number K223440 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 14, 2022
Decision Date March 02, 2023
Days to Decision 108 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QVJ — Low Power Electrosurgical Devices For Skin Lesion Destruction
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4400
Definition For The Removal And Destruction Of Skin Lesions In General Dermatological Procedures, Also Referred To As Plasma Pen Devices, Which Generates Electrical Arc In The Ambient Air Between An Electrical Probe Tip And The Skin And Cause Intended Tissue Damage For The Removal And Destruction Of Skin Lesions